Treatment Registry
TR-0459 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by MedLeanRx · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$269

Medication · Tirzepatide injections, starting price$269

Added from the figures recorded below.

Price

TermPer monthCharged today
Tirzepatide injections, starting price

Tirzepatide injections starting at $269/mo. No hidden fees, no surprise charges. Cancel anytime.

source

Per month$269Charged today$269
Visit MedLeanRx

We earn nothing from this link. MedLeanRx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesNot disclosed as of September 3, 2026
PrescriberAsynchronous review
Cancellation“MedLeanRX Payment, Subscription & No-Refund Policy MedLeanRx maintains a strict NO REFUND policy for consultations, provider reviews, subscription fees, administrative fees, membership fees, and services already rendered.”
MembershipOptional. $99 per month. “FDA-Approved FDA-Approved Oral Wegovy® Semaglutide Wegovy® Pill $99 /mo + medication cost”

Not yet checked: pharmacy and consult fee.

Recorded from medleanrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Contradiction: the homepage badges advertise 'Cancel Anytime,' while the Terms page states a strict NO-REFUND policy covering subscription/membership/admin fees. The '$99/mo + medication cost' Wegovy Pill tier explicitly excludes medication and is recorded as membership, not a price, per the brief's rule. Terms also state 'MedLeanRX Services are not available in all 50 states,' consistent with the Texas-only marketing.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0459
Readings
1

Related records

What else MedLeanRx sells

All MedLeanRx programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). MedLeanRx compounded tirzepatide (TR-0459). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0459

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.